semaglutide gray India's generic surge | Opinion All you need to know
Description
Federal regulators on Tuesday told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal thoughts and behaviors from their blo

Learn about the relationship between tirzepatide (Mounjaro, Zepbound) and sexual function, including how weight loss impacts hormones, when to talk to your doctor, and what factors influence sexual health during treatment.
Learn about the differences between these treatments, how each works, and what else to consider.

The good, the bad and the ugly

Who its for

The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial programme demonstrated that adults using semaglutide 2.4 mg weekly alongside lifestyle intervention lost an average of approximately 15% of their body weight over 68 weeks, compared to around 2.4% with placebo. NICE approved Wegovy for use in specialist weight management services in the UK in 2023 (TA875), recognising its clinical effectiveness. Ongoing research continues to explore its cardiovascular benefits, with the SELECT trial showing a significant reduction in major cardiovascular events in people with obesity
